OverviewSuggest Edit

TFF Pharmaceuticals is a biopharmaceutical company focused on developing drug products based on the Thin Film Freezing (TFF) technology platform. It develops inhalation drug products to treat chronic respiratory diseases and lung conditions. The company generates dry powder inhaler version of drugs.
TypePublic
Founded2018
HQAustin, TX, US
Websitetffpharma.com

Latest Updates

Employees (est.) (Dec 2019)4(-42%)
Share Price (May 2022)$4.5(-4%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at TFF Pharmaceuticals

Brian Windsor

Brian Windsor

Director & CSO
Glenn Mattes

Glenn Mattes

President, Chief Executive Officer and Director
Kirk Coleman

Kirk Coleman

Chief Financial Officer
Aaron Fletcher

Aaron Fletcher

Chairman of the Board
Stephen Rocamboli

Stephen Rocamboli

Director
Robert S. Mills

Robert S. Mills

Director
Show more

TFF Pharmaceuticals Office Locations

TFF Pharmaceuticals has an office in Austin
Austin, TX, US (HQ)
2600 Vía Fortuna #360
Show all (1)

TFF Pharmaceuticals Financials and Metrics

TFF Pharmaceuticals Revenue

USD

Net income (FY, 2020)

(18.6m)

EBIT (FY, 2020)

(18.7m)

Market capitalization (6-May-2022)

114.2m

Closing stock price (6-May-2022)

4.5

Cash (31-Dec-2020)

35.3m
TFF Pharmaceuticals's current market capitalization is $114.2 m.
Annual
USDFY, 2018FY, 2019FY, 2020

General and administrative expense

3.0m3.2m8.0m

R&D expense

848.8k8.8m10.7m

Operating expense total

3.9m12.0m18.7m

EBIT

(3.9m)(12.0m)(18.7m)
Quarterly
USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

General and administrative expense

465.9k531.6k889.5k300.6k1.6m1.3m2.3m

R&D expense

140.2k1.7m1.3m2.6m2.2m2.6m2.8m

Operating expense total

606.1k2.2m2.2m2.9m3.9m3.8m5.1m

EBIT

(606.1k)(2.2m)(2.2m)(2.9m)(3.9m)(3.8m)(5.1m)
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

10.3m28.1m35.3m

Prepaid Expenses

12.1k1.1m2.3m

Current Assets

10.3m29.2m37.6m

PP&E

1.1m
Quarterly
USDQ2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

13.6m10.6m25.7m21.9m41.6m

Prepaid Expenses

27.1k20.3k859.1k610.4k595.0k

Current Assets

13.7m10.6m26.6m22.5m42.2m

PP&E

945.4k
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(3.8m)(11.9m)(18.6m)

Accounts Payable

398.2k12.4k862.7k

Cash From Operating Activities

(2.1m)(11.2m)(16.6m)

Purchases of PP&E

(1.1m)
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

(2.4m)(3.0m)(2.2m)(4.4m)(7.2m)(3.8m)(7.6m)(12.7m)

Accounts Payable

664.2k426.8k(25.7k)(60.8k)181.3k796.2k274.3k501.9k

Cash From Operating Activities

(562.2k)(1.3m)(2.1m)(3.8m)(6.9m)(2.4m)(6.1m)(10.4m)

Purchases of PP&E

(293.2k)
Show all financial metrics

TFF Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

TFF Pharmaceuticals Online and Social Media Presence

Embed Graph

TFF Pharmaceuticals News and Updates

TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)

Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering Antivirals, Antibodies and Vaccines using Thin Film Freezing Technology in the Fight Against COVID-19

TFF Pharmaceuticals to Hold First Quarter 2022 Financial and Business Results Conference Call on May 11, 2022

Company conference call and webcast at 4:30 PM ET Company conference call and webcast at 4:30 PM ET

TFF Pharmaceuticals Announces Safety and Pharmacokinetic Data from Phase 1 Study of Niclosamide Inhalation Powder

Niclosamide Inhalation Powder Well Tolerated with No Serious Adverse Events Across All Subject Cohorts

TFF Pharmaceuticals Enters into CRADA with the U.S. Army and The Geneva Foundation to Develop Dry Powder Needle-free Medical Countermeasures

New collaboration to study the use of Thin Film Freezing technology to formulate dry powder recombinant vaccine against SARS-CoV-2 for pulmonary delivery New collaboration to study the use of Thin Film Freezing technology to formulate dry powder recombinant vaccine against SARS-CoV-2 for pulmonary d…

TFF Pharmaceuticals to Participate at the 34th Annual Roth Conference

AUSTIN, Texas, March 11, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that Preside…

TFF Pharmaceuticals and Catalent Announce New Inhalation Dry Powder Development and Manufacturing Agreement

AUSTIN, Texas and SOMERSET, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) and Catalent today announced their collaboration agreement focused on the generation, testing and manufacture of dry powder formulations for a range of biotherapeutics through the applicat…
Show more

TFF Pharmaceuticals Blogs

TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference

FORT WORTH, Texas , May 20, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals , Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that

TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update Content Import Wed, 05/11/2022 - 16:01 TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update May 11, 2022 at 4:01 PM EDT Earni…

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update Content Import Thu, 03/24/2022 - 16:27 TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update March 24, 2022 at …

TFF Pharmaceuticals to Hold Fourth Quarter and Full Year 2021 Financial and Business Results Conference Call on March 24, 2022

Company conference call and webcast at 4:30 PM ET AUSTIN, Texas , March 09, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals , Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing

TFF Pharmaceuticals to Hold Third Quarter 2021 Financial and Business Results Conference Call on November 15, 2021

Company conference call and webcast at 4:30 PM ET AUSTIN, Texas , Nov. 05, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF)

TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update Content Import Thu, 08/12/2021 - 16:01 TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update August 12, 2021 at 4:01 PM EDT …
Show more

TFF Pharmaceuticals Frequently Asked Questions

  • When was TFF Pharmaceuticals founded?

    TFF Pharmaceuticals was founded in 2018.

  • Who are TFF Pharmaceuticals key executives?

    TFF Pharmaceuticals's key executives are Brian Windsor, Glenn Mattes and Kirk Coleman.

  • How many employees does TFF Pharmaceuticals have?

    TFF Pharmaceuticals has 4 employees.

  • Who are TFF Pharmaceuticals competitors?

    Competitors of TFF Pharmaceuticals include Nuvaira, Gentex Pharma and Lung Therapeutics.

  • Where is TFF Pharmaceuticals headquarters?

    TFF Pharmaceuticals headquarters is located at 2600 Vía Fortuna #360, Austin.

  • Where are TFF Pharmaceuticals offices?

    TFF Pharmaceuticals has an office in Austin.

  • How many offices does TFF Pharmaceuticals have?

    TFF Pharmaceuticals has 1 office.